About S.C MedLife S.A
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Hoffmann-La Roche
4
Pfizer
3
Arena Pharmaceuticals
2
AstraZeneca
2
Celgene
2
BeiGene
1
Eiger BioPharmaceuticals
1
Samsung Bioepis Co., Ltd.
1
Sumitomo Pharma Oncology, Inc.
1
Clinical Trials at S.C MedLife S.A
During the past decade, S.C MedLife S.A conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on
average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
2014-12-24
2020-06-23
Completed
397
A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
2014-10-01
2017-09-20
Completed
714
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
2015-12-08
2018-01-05
Terminated
701
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
2016-07-25
2018-01-04
Terminated
310
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "S.C MedLife S.A" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials
sponsored, "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "AstraZeneca"
with 2 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "S.C MedLife S.A"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at S.C MedLife S.A
According to Clinical.Site data, the most researched conditions in "S.C MedLife S.A" are
"Crohn's Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Crohn Disease" (3 trials), "Advanced or Inoperable Gastric Cancer" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "S.C MedLife S.A" in a lesser frequency.
Clinical Trials Intervention Types at S.C MedLife S.A
Most popular intervention types in "S.C MedLife S.A" are "Drug" (21 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Mirikizumab" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.
Clinical Trials Genders at S.C MedLife S.A
The vast majority of trials in "S.C MedLife S.A" are
21 trials for "All" genders.
Clinical Trials Status at S.C MedLife S.A
Currently, there are NaN active trials in "S.C MedLife S.A".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in S.C MedLife S.A,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in S.C MedLife S.A, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of S.C MedLife S.A
S.C MedLife S.A has several departments that took part in Clinical trials: "MedLife, Gastroenterologie" - 4 trials
Departments List
Name
City
Trials